Bioaerosol Exposures and Respiratory Diseases in Cannabis Workers.
Curr Allergy Asthma Rep
; 24(7): 395-406, 2024 Jul.
Article
em En
| MEDLINE
| ID: mdl-38878249
ABSTRACT
PURPOSE OF REVIEW This review investigates occupational inhalation hazards associated with biologically derived airborne particles (bioaerosols) generated in indoor cannabis cultivation and manufacturing facilities. RECENT FINDINGS:
Indoor cannabis production is growing across the US as are recent reports of respiratory diseases among cannabis workers, including occupational asthma morbidity and mortality. More information is needed to understand how bioaerosol exposure in cannabis facilities impacts worker health and occupational disease risk. Preliminary studies demonstrate a significant fraction of airborne particles in cannabis facilities are comprised of fungal spores, bacteria, and plant material, which may also contain hazardous microbial metabolites and allergens. These bioaerosols may pose pathogenic, allergenic, toxigenic, and pro-inflammatory risks to workers. The absence of multi-level, holistic bioaerosol research in cannabis work environments necessitates further characterization of the potential respiratory hazards and effective risk prevention methods to safeguard occupational health as the cannabis industry continues to expand across the US and beyond.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Cannabis
/
Exposição Ocupacional
/
Aerossóis
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article